Skip to content
Dose Brief
Menu
No. 303 here · Grade C

System Labs review

A single-molecule tirzepatide desk with the simplest price in this ranking — $179 a month, flat, month-to-month, the same at every dose — sold behind a $99 first-month headline, by a company that names its doctors but not its pharmacy and publishes no list of states it can serve.

Visit System Labs Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
Not offered — no semaglutide is sold here at any price
Tirzepatide
$179/mo flat, month-to-month, the same at every dose — the $99 beside it is a first-month intro rate, not the ongoing one
Coverage
Coverage not published
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior reading— First reading, 8 August 2026. One rate, one cadence: $179 a month, flat, month-to-month, identical at every dose — the FAQ commits to it in those words and the buy box sells a single "Monthly Supply (All doses)" line. No three-, six- or twelve-month rung exists, so there is no prepay figure here to mistake for a monthly one. The $99 printed beside it is a first-month intro rate, labeled "/first mo." on the page and flagged as an intro in the lander's own commerce data; month two is $179. Tirzepatide only — no semaglutide is sold at any price.

The scorecard

System Labs scored on our six Brief Score factors. See the methodology.

Price Stability70/100
Supply Reliability58/100
Transparency54/100
Access Breadth42/100
Clinical Oversight70/100
Track Record58/100

What we like

  • One price, one cadence, and the FAQ says so in its own words: "Your subscription is billed at a flat $179/mo with no hidden fees." No membership fee, no per-visit fee, and shipping is included rather than added at checkout
  • The rate is dose-flat — the buy box sells a single "Monthly Supply (All doses)" line — so titrating up to a maintenance dose does not move the bill, which is the question most desks in this ranking answer badly or not at all
  • There is no term ladder to misread, because there is no term ladder: month-to-month is the only cadence sold. The commonest pricing failure in this ranking — a twelve-month prepay rung printed as a monthly rate — is structurally impossible here
  • Names a medical board with real, checkable credentials rather than stock portraits: Dr. Marc Gruner (sports medicine, trained at Mayo Clinic), Dr. Jonathan Hinds (board-certified emergency medicine, trained at Rutgers) and Dr. Gregory Tennant (fellowship-trained orthopedic trauma surgeon, trained at Vanderbilt)
  • Free two-day temperature-controlled shipping with injection supplies included, refills issued automatically against your titration schedule, and pause or cancel self-serve from the dashboard at any time
  • Discloses on the lander itself, in bold, that the compounded product is not FDA-approved — and it is clean against FDA's warning-letter index under its legal entity, its brand and its domain, screened 8 August 2026 across the complete 3,651-row index with a passing positive control

The caveats

  • The first number on the page is not the price. $179 is struck through beside "$99 /first mo.", and the lander's own commerce data marks that $99 an intro rate — month two is $179, and a reader who budgets on the headline is budgeting on a rate that lasts four weeks
  • One molecule only. This is a tirzepatide desk: no semaglutide is sold at any price, so anyone who came for a semaglutide quote, or whose clinician has already put them on one, has nothing to compare here
  • The dispensing pharmacy is not named. "A certified U.S. pharmacy" is the entire disclosure — no name, no state, no 503A/503B distinction and no accreditation seal, so nothing about who actually compounds the drug can be checked from outside
  • No list of states served is published anywhere. One physician is described as licensed in all 50 states, which is a fact about him rather than a coverage claim about the desk, so there is no way to confirm you can be treated before starting the intake
  • The clinicians who actually write the prescription are not named and no NPI is published for anyone, including the three doctors on the medical board — and the screen itself is a two-minute intake form reviewed asynchronously, at the light end of this ranking
  • Compounded tirzepatide is not an FDA-approved product and is not a generic Zepbound or Mounjaro, and no brand-name route is offered here at any price
  • The testimonials carry no verifiable identity — first name and age only — and several of them praise the NAD+ and glutathione lines rather than the GLP-1 program, so they are not evidence about the thing being sold on this page

The brief

Best for: Readers who want one predictable tirzepatide bill they can cancel next month, and who will read the "/first mo." on the $99 before budgeting around it — not readers who came for semaglutide, or who need to confirm their state before starting an intake. A single-molecule tirzepatide desk with the simplest price in this ranking — $179 a month, flat, month-to-month, the same at every dose — sold behind a $99 first-month headline, by a company that names its doctors but not its pharmacy and publishes no list of states it can serve.

Ranked #303 of 509 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Visit System Labs

Closest here

The desks scoring nearest System Labs — the realistic shortlist if you're weighing it.

Weighing System Labs against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs System Labs, and every desk that outranks it is listed on the System Labs alternatives ranking.

More desks we track (24)

478 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect System Labs's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on System Labs's site. Not medical advice; see our disclosure.

← Back to all rankings